Nucleo is an advanced AI-driven platform designed to automate CT scan analysis in oncology care, enhancing diagnostic accuracy and efficiency. By leveraging cutting-edge artificial intelligence, Nucleo streamlines critical processes in cancer diagnostics, reducing the time and potential for human error associated with manual assessments.
Key Features and Functionality:
- Body Composition and Sarcopenia Assessment: Automatically detects and quantifies fat and muscle mass in CT scans, aiding in the evaluation of patient health and treatment planning.
- Tumor Lesion Sizing: Provides precise and consistent measurements of tumor lesions, ensuring accurate monitoring of disease progression or response to therapy.
- Target vs. Non-Target Lesion Classification: Automates the classification of lesions according to RECIST criteria, standardizing assessments and facilitating clear communication among healthcare professionals.
Primary Value and User Solutions:
Nucleo addresses the challenges of manual CT scan analysis by offering a faster, more reliable alternative. Its AI technology reduces the time required for image interpretation, minimizes variability between assessments, and supports clinicians in making informed decisions. By automating complex diagnostic tasks, Nucleo enhances workflow efficiency, improves patient outcomes, and allows healthcare providers to focus more on patient care rather than time-consuming manual processes.